Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/69386
Type
ArticleCopyright
Open access
Collections
- ENSP - Artigos de Periódicos [2412]
Metadata
Show full item record
FATALITY FROM COVID-19 DOES NOT AFFECT PALLIATIVE CARE DURATION AMONG PATIENTS WITH ADVANCED CANCER: A RETROSPECTIVE COHORT STUDY
Neoplasms
Underlying cause of death
Palliative care
Pandemics
Survival
Cause of death
Author
Affilliation
Instituto Nacional de Câncer. Rio de Janeiro, RJ, Brasil.
Instituto Nacional de Câncer. Rio de Janeiro, RJ, Brasil.
Instituto Nacional de Câncer. Rio de Janeiro, RJ, Brasil.
Instituto Nacional de Câncer. Rio de Janeiro, RJ, Brasil.
Instituto Nacional de Câncer. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sergio Arouca. Rio de Janeiro, RJ, Brasil.
Instituto Nacional de Câncer. Rio de Janeiro, RJ, Brasil.
Instituto Nacional de Câncer. Rio de Janeiro, RJ, Brasil.
Instituto Nacional de Câncer. Rio de Janeiro, RJ, Brasil.
Instituto Nacional de Câncer. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sergio Arouca. Rio de Janeiro, RJ, Brasil.
Abstract
Objective: This study aimed at investigating the extent to which COVID-19-induced fatalities affect the duration of palliative care among patients with advanced cancer. Methods: A retrospective
cohort study was conducted at the Palliative Care Unit of the Brazilian Instituto Nacional de Câncer in Rio de Janeiro, Brazil, on 1,104 advanced cancer patients who died under exclusive palliative
care between March 11, 2020, and March 31, 2021. Wilcoxon rank-sum (Mann-Whitney U) and log-rank tests were performed to examine statistical differences between the medians of time, and
the Kaplan-Meier estimator was used to graphically illustrate survival over time under exclusive palliative care contingent upon the underlying causes of death of the two experimental groups
(cancer versus COVID-19). Results: A total of 133 (12.05%) patients succumbed to COVID-19. In both groups, the median time under exclusive palliative care was less than one month. The
exclusive palliative care survival curves did not exhibit any statistically significant difference between the groups. Conclusion: Death due to COVID-19 did not modify the duration of exclusive
palliative care among patients with advanced cancer.
Keywords
COVID-19Neoplasms
Underlying cause of death
Palliative care
Pandemics
Survival
Cause of death
Share